[go: up one dir, main page]

WO2009145358A3 - Medicament for the prophylaxis or treatment of hypertension - Google Patents

Medicament for the prophylaxis or treatment of hypertension Download PDF

Info

Publication number
WO2009145358A3
WO2009145358A3 PCT/JP2009/060295 JP2009060295W WO2009145358A3 WO 2009145358 A3 WO2009145358 A3 WO 2009145358A3 JP 2009060295 W JP2009060295 W JP 2009060295W WO 2009145358 A3 WO2009145358 A3 WO 2009145358A3
Authority
WO
WIPO (PCT)
Prior art keywords
hypertension
prophylaxis
medicament
treatment
blocker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2009/060295
Other languages
French (fr)
Other versions
WO2009145358A2 (en
Inventor
Makoto Mizuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of WO2009145358A2 publication Critical patent/WO2009145358A2/en
Publication of WO2009145358A3 publication Critical patent/WO2009145358A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to a medicament for the prophylaxis or treatment of hypertension or a disease caused by hypertension comprising (A) an angiotensin Il receptor blocker, (B) at least one calcium channel blocker and (C) at least one diuretic.
PCT/JP2009/060295 2008-05-30 2009-05-29 Medicament for the prophylaxis or treatment of hypertension Ceased WO2009145358A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008142380 2008-05-30
JP2008-142380 2008-05-30

Publications (2)

Publication Number Publication Date
WO2009145358A2 WO2009145358A2 (en) 2009-12-03
WO2009145358A3 true WO2009145358A3 (en) 2010-05-06

Family

ID=41058543

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2009/060295 Ceased WO2009145358A2 (en) 2008-05-30 2009-05-29 Medicament for the prophylaxis or treatment of hypertension

Country Status (2)

Country Link
TW (1) TW201000097A (en)
WO (1) WO2009145358A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103127110A (en) * 2013-03-18 2013-06-05 吉林省博大伟业制药有限公司 Compound preparation containing angiotensin II receptor antagonist and calcium channel blocker
CZ2015687A3 (en) * 2015-10-02 2017-04-12 Zentiva, K.S. A pharmaceutical composition comprising a combination of candesartan, amlodipine and hydrochlorothiazide
CN115645402A (en) * 2022-11-22 2023-01-31 浙江工业大学 Application of Aredipine in the Preparation of Drugs for Treating or Preventing Acute Myocardial Infarction

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050187262A1 (en) * 2004-01-12 2005-08-25 Grogan Donna R. Compositions comprising (S)-amlodipine and an angiotensin receptor blocker and methods of their use
WO2008032107A1 (en) * 2006-09-15 2008-03-20 Daiichi Sankyo Company Limited Solid dosage form of olmesartan medoxomil and amlodipine
WO2009113420A1 (en) * 2008-03-13 2009-09-17 第一三共株式会社 Improvement of dissolvability of preparation containing olmesartan medoxomil

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050187262A1 (en) * 2004-01-12 2005-08-25 Grogan Donna R. Compositions comprising (S)-amlodipine and an angiotensin receptor blocker and methods of their use
WO2008032107A1 (en) * 2006-09-15 2008-03-20 Daiichi Sankyo Company Limited Solid dosage form of olmesartan medoxomil and amlodipine
WO2009113420A1 (en) * 2008-03-13 2009-09-17 第一三共株式会社 Improvement of dissolvability of preparation containing olmesartan medoxomil

Also Published As

Publication number Publication date
WO2009145358A2 (en) 2009-12-03
TW201000097A (en) 2010-01-01

Similar Documents

Publication Publication Date Title
WO2009002947A3 (en) Compounds and peptides that bind the trail receptor
WO2010077836A3 (en) Pyrrolidine compounds which modulate the cb2 receptor
WO2008040649A3 (en) Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2005079756A3 (en) Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
PL2029642T3 (en) Catalyst composition for the copolymerization of propylene.
BRPI1013984A2 (en) compound, pharmaceutical composition, method for treating or prophylaxis of a disease or condition, and use of a compound.
PL1984357T3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
WO2007133802A3 (en) Pharmaceutical formulations of pimavanserin
WO2008115281A3 (en) Compounds for treating viral infections
WO2007127292A3 (en) Tigeycline crystalline forms and processes for preparation thereof
WO2009089234A3 (en) Substituted dibenzhydrylpiperazines
CL2007003637A1 (en) PROCEDURE FOR THE PREPARATION OF BENZIMIDA PIPERACINILO AND DIAZEPANILO DERIVATIVES USEFUL FOR THE TREATMENT OF DISORDERS AND INTERMEDIATE CONDITIONS BY A HISTAMINE RECEIVER.
MX2010000724A (en) Method for reducing intracranial pressure.
WO2009142738A3 (en) Compositions and methods for diagnosing and treating cancer
EP4374915A3 (en) Compositions for the treatment of hypertension
WO2008075173A3 (en) Methods for treating podocyte-related disorders
MY160432A (en) Antihypertensive pharmaceutical composition
WO2010077976A3 (en) Prokineticin receptor antagonists and uses thereof
WO2012007846A3 (en) A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
MX2009012427A (en) Spirocyclopropyl piperidine derivatives.
WO2009106951A8 (en) A device for reducing a bone fracture
WO2007103584A3 (en) Polyamides for treating human papilloma virus
WO2009145358A3 (en) Medicament for the prophylaxis or treatment of hypertension
WO2008009860A3 (en) Use of calcium channel antagonist compounds for depigmenting the skin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09754866

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 09754866

Country of ref document: EP

Kind code of ref document: A2